Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Biosimulation Market Trends, Opportunity Analysis, Application and Forecast 2016-2022

Monday, January 9, 2017 23:47
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Biosimulation is explained as a computer-aided mathematical simulation of biological processes and systems and hence is an integral part of systems biology. The main aim of Biosimulation is model-based prediction of the behavior and the dynamics of biological systems e.g. the response of an organ or a single cell towards a chemical. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials.
The demand for Biosimulation market is expected to increase in forecasted period due to increase in the factors such as use of personalized medicine. 
Factors that are driving the market are: Increase in the use of personalized medicine also continuous research and development is going on in the field which has led to the improvement and simulation of modeling tools, also the growth in the biotechnological and pharmaceutical industries has helped Biosimulation industry to grow. Also, the industry is expecting growth due to the boom in drugs market as a result of increase in ageing population and increasing number of chronic diseases. Some of the factors which are restraining the market are shortage of skilled professionals, higher cost of the process, lack of standardized tools and applications and limited knowledge about biological process.

 For more information http://www.reportsweb.com/global-biosimulation-market-insights-opportunity-analysis-market-shares-and-forecast-2016-2022 .

The market of Biosimulation market is segmented on the basis of products, end user, application, drug development. Geographically the market is divided in to North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, rest of Europe), Asia-Pacific (India, Japan, Australia, China, Korea, Rest of Asia Pacific) and Rest of World (Latin America, MENA and Africa). The key providers of biosimulation technology are Certara, Biovia, Dassault Systèmes.
Companies profile include
1. Certara USA, Inc.
2. Rhenovia Pharma Ltd. 
3. Physiomics PLC 
4. Genedata Ag 
5. Entelos Holding Corporation
6. Chemical Computing Group, Inc.
7. Advanced Chemistry Development, Inc. 
8. Schrödinger Inc. 
9. Dassault Systèmes SA 
10. Simulation Plus Inc. 
11. Biovia (Formerly Accelrys) 
12. In silico biosciences
13. Inhibox 
14. Leadinvent Technologies
15. Leadscope
16. Nimbus therapeutics
17. Open eye Scientific software
18. Physiomics Plc.
19. Rhenovia Pharma
20. Genedata
This Publisher Report covers
1. Historical data
2.Revenue forecasts, growth rates and CAGR up to 2022
3.Industry Analysis
4.Competitive Analysis
5. Key geographic growth data

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001329427/sample .

Companies Mentioned:

1   Certara USA, Inc
2   Rhenovia Pharma Ltd
3   Physiomics PLC 
4   Genedata Ag 
5   Entelos Holding Corporation
6   Chemical Computing Group, Inc
7   Advanced Chemistry Development, Inc
8    Schrödinger Inc
9    Dassault Systèmes SA 
10  Simulation Plus Inc
11  Biovia (Formerly Accelrys) 
12  In silico biosciences
13  Inhibox
14  Leadinvent Technologies
15  Leadscope
16  Nimbus therapeutics
17  Open eye Scientific software
18  Physiomics Plc
19  Rhenovia Pharma
20  Genedata

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001329427/buying .

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.